Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.003 Å; R factor = 0.044; wR factor = 0.117; data-to-parameter ratio = 16.7.
In the title compound, C 14 H 11 ClN 2 O 2 , two independent molecules (A and B) comprise the asymmetric unit with the main difference between them being the relative orientation of the pendent phenyl ring with respect to the fused-ring system [dihedral angles = 8.32 (8) (A) and 28.32 (8) (B)]. In the crystal, the A molecules are connected into a linear supramolecular chain along the a axis via C-HÁ Á ÁO interactions and linked to this via C-HÁ Á ÁCl interactions are the B molecules. The chains are connected into layers in the ab plane byinteractions between pyrazole (A) and pyran (B) rings, and between pyrazole (B) and pyran (A) rings [centroid-centroid distances = 3.5442 (11) and 3.4022 (10) Å , respectively].
Related literature
For the analgesic and anti-inflammatory activity of pyrano[2,3c]pyrazole derivatives, see: Kuo et al. (1984) . For the synthesis, see: Gelin et al. (1983) . For the structure of the derivative without a chloro substituent, see: Asiri et al. (2012) Table 1 Hydrogen-bond geometry (Å , ). Data collection: CrysAlis PRO (Agilent, 2012); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010). 
5-Chloro

Tiekink Comment
In connection with reports that pyrano[2,3-c]pyrazole derivatives possess analgesic and anti-inflammatory activities (Kuo et al., 1984) , the title compound (I) was synthesized, following a literature procedure (Gelin et al., 1983) , and its crystal and molecular structure are reported on herein.
In (I), Fig. 1 , two independent molecules comprise the asymmetric unit. As seen from the overlay diagram, Fig In the crystal, the Cl1-containing molecules are connected into a linear supramolecular chain along the a axis via C-H···O interactions and linked to this via C-H···Cl interactions are the Cl2-containing molecules, Fig. 3 and Table 1 .
Chains are connected into layers in the ab plane by π-π interactions with the closest of these occurring between the fivemembered and six-membered in an alternating sequence of the independent molecules [ring centroid(N1-pyrazole)···(O3pyrano) i = 3.5442 (11) Å, angle of inclination = 2.29 (11)° for i: -x+1, -y, -z+1; ring centroid(N3-pyrazole)···(O1-pyrano) ii = 3.4022 (10) Å, angle of inclination = 5.38 (8)° for ii: x+1/2, -y+1/2, -z+1]. The layers stack along the c axis with no specific intermolecular interactions between them, Fig. 4 .
Experimental
To a solution of 4-(acetoacetyl)-3-methyl-1-phenyl-2-pyrazolin-5-one (0.01 M), made following a literature procedure (Gelin et al., 1983) , in dry methylene chloride (20 ml) was added drop-wise sulfuryl chloride (1.35 g, 0.01 M). The mixture was allowed to stand at room temperature for 2 h and then poured into a 10% aqueous K 2 CO 3 solution (50 ml)
with stirring for 5 min. The aqueous layer was acidified with 10% HCl and extracted with chloroform. The combined organic extracts were washed with water and dried (Na 2 SO 4 ). Removal of the solvent gave 4-(aceto-chloroacetyl)-3methyl-1-phenyl-2-pyrazolin-5-one. Concentrated sulfuric acid (1 ml) was then added drop-wise. After 4 h at room temperature, the mixture was poured into ice-water (200 ml). The precipitate was extracted with chloroform. The chloroform layer was washed with 5% aqueous K 2 CO 3 solution, dried and evaporated to give the title compound which was recrystallized from ethanol. M.p: 413-415 K cf. Lit. M.p. 413 K (Gelin et al., 1983) . Yield: 68%.
Refinement
C-bound H-atoms were placed in calculated positions and included in the refinement in the riding model approximation:
C-H = 0.95 and 0.98 Å for CH and CH 3 H-atoms, respectively, with U iso (H) = k × U eq (C) where k = 1.5 for CH 3 Hatoms and = 1.2 for other H-atoms. 
Computing details
Data collection: CrysAlis PRO (Agilent, 2012); cell refinement: CrysAlis PRO (Agilent, 2012); data reduction: CrysAlis PRO (Agilent, 2012); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010).
Figure 1
The molecular structure of the two independent molecules of (I), showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level. 
Figure 4
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